IFNA1 and systemic lupus erythematosus: The above data support a pathogenic model in which these auto-antibodies chronically stimulate the endosomal TLR system, and specific IRF5 variants in conjunction with particular autoantibodies dysregulate IFN-α production, resulting in increased risk of SLE (Figure 3) [64].